PAM
CLCD

Panagora Asset Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Panagora Asset Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,891
Closed -$123K – 2430
2015
Q3 		$123K Buy
31,891
+8,552
+37% +$63.2K ﹤0.01% 1758
2015
Q2 		$208K Buy
+23,339
New +$200K ﹤0.01% 1660

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Panagora Asset Management's CLCD Position: Q4 2015 in Review

Panagora Asset Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q4 2015, closing a stake of 31,891 shares — an estimated $123K sold.

Panagora Asset Management first reported a position in CLCD in Q2 2015 and held it in 2 quarters. The position peaked at $208K in Q2 2015. 21 funds tracked by Wall St. Rank hold CLCD as of Q4 2015.

  • Panagora Asset Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Panagora Asset Management sold 31,891 CoLucid Pharmaceuticals, Inc. shares in Q4 2015, an estimated $123K.
  • Panagora Asset Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
  • Panagora Asset Management's CoLucid Pharmaceuticals, Inc. position peaked at $208K in Q2 2015.
  • 21 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q4 2015.

Based on Panagora Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.